Gear Up for Royalty Pharma (RPRX) Q2 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 08/04/26
Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic InitiativesGlobeNewsWire • 08/03/26
Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from NeurimmuneGlobeNewsWire • 07/22/26
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026GlobeNewsWire • 07/15/26
Are You Looking for a Top Momentum Pick? Why Royalty Pharma (RPRX) is a Great ChoiceZacks Investment Research • 07/10/26
Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 07/10/26
Royalty Pharma plc (RPRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare ConferenceGlobeNewsWire • 06/04/26
Royalty Pharma plc (RPRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/19/26
Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower AheadSeeking Alpha • 05/16/26
Royalty Pharma PLC (RPRX) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 05/06/26
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific InnovationGlobeNewsWire • 04/21/26